AN ACT CONCERNING PRESCRIPTION DRUG SHORTAGES, PRESCRIPTION DRUG REBATES AND PROHIBITED MANUFACTURER PRACTICES CONCERNING CERTAIN PRESCRIPTION DRUGS.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 9 Sponsors

Apr 7, 2026 · Senate

RPTD. OUT OF LCO

Apr 7, 2026 · Senate

FAV. RPT., TAB. FOR CAL., SEN.

Apr 7, 2026 · Senate

SENATE CALENDAR NUMBER 295

Apr 7, 2026 · Senate

FILE NO. 483

Mar 30, 2026 · Senate

REFERRED TO Office of Legislative Research AND Office of Fiscal Analysis 04/07/26

Mar 20, 2026 · Senate

FILED WITH LCO

Mar 19, 2026 · Senate

Joint Favorable Substitute

Mar 13, 2026 · Senate

PUBLIC HEARING 0317

Mar 12, 2026 · Senate

REF. TO JOINT COMM. ON Human Services

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Floor Consideration — base rate 20%, measured from CT's completed sessions
Momentum -2 42/100 from the pace of recorded action
Time since last action -22 187 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.